Other Transaction Agreement W81XWH209C001
Award Date
1/28/20
Potential Completion Date
12/31/23
Potential Value
$18M
Federal Agency
Medical Command
Ultimate Awardee
Not listed
NAICS Category
Not listed
PSC Category
AN94 - R&D- Medical: Other (Engineering Development)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Netherlands
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a $11.6 million delivery order against its Medical Product Research and Development master IDIQ contract to PPD Development LP. This cost-plus-fixed-fee order is to provide clinical monitoring services for a Phase 2B proof of concept study being conducted in South Africa. The study aims to develop an HIV vaccine that meets the requirements of the U.S. Military. Performance will take place in South Africa over a five year period concluding in October 2022. No set...
This definitive cost-no-fee contract was awarded by the Defense Health Agency to Universitaetsklinikum Essen Anstalt DES Oeffentlichen Rechts, doing business as Universitatsklinikum Essen, to establish up to 10 clinical sites for a cohort study seeking to enroll 1,000 men who have sex with men exhibiting high-risk sexual behavior. The purpose of the study is to estimate HIV incidence in this population and determine the feasibility of future HIV vaccine efficacy trials. The potential value of...
This is a $93,164,303.39 cost plus fixed fee definitive contract awarded by the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization, on September 14, 2015. The contract has an ultimate completion date of August 16, 2024 and is not set-aside. The contract is for products and services related to HHS's preparedness and response programs, though...
This is a $48,482,241.10 Other Transaction Agreement awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF) for PROTOTYPE EBOLA CLINICAL TRIALS, JMEDICC. The contract has a completion date of December 31, 2022 and was awarded on July 2, 2019. HJF is a non-profit organization that supports the U.S. Military Health System through research, education, and...
This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $1,937,251.00, is for the design and development of preventative HIV vaccines. The contract has an ultimate completion date of April 30, 2018 and was awarded on October 31, 2015. The contract is a definitive contract with a cost no fee pricing type and does...
This is a federal contract award to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF), a non-profit organization, by the U.S. Army Medical Command (MEDCOM). The contract is for $16,673,175.21 to provide non-personal services support to the Walter Reed Army Institute of Research (WRAIR), U.S. Military HIV Research Program (MHRP), Department of Laboratory Diagnostics and Monitoring (DLDM), and Department of Epidemiology and Threat Assessment (DETA). The...
This federal contract award, HHSN272201600011C, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to the University of Massachusetts Medical School (UMMS) for "STAGED VACCINE DEVELOPMENT". The $17,298,573.00 cost-no-fee contract does not have a set-aside designation. Under this contract, UMMS serves as the prime contractor and has subcontracted a portion of the work to the University...
<p>This is a cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization. The $196,408,488.00 contract does not have a set-aside designation and has an ultimate completion date of March 30, 2026. The contract was awarded on September 28, 2017.</p>
This federal contract award is for HIV force testing services for the U.S. Army Medical Command (MEDCOM). The $6,303,692.40 firm fixed price delivery order was awarded to Center for Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings that specializes in infectious disease testing for government agencies. The work will be performed in San Antonio, Texas and supports the military's efforts to monitor and address HIV prevalence among service members. This award is...
The Department of the Army Materiel Command Communications Electronics Command awarded Pfizer Inc., doing business as Pfizer, a definitive contract valued at $11.3 billion for the production of COVID-19 vaccines. Under the terms of the firm fixed price contract, Pfizer will deliver vaccines to the Army Materiel Command from its New York location between December 2020 and June 2023. The funding agency, Army Materiel Command Communications Electronics Command, is a component of the Department of...